| |
KO |
Metabolism
|
|
|
Genetic Information Processing
|
|
|
Environmental Information Processing
|
|
|
Cellular Processes
|
|
|
Organismal Systems
|
|
|
Human Diseases
|
|
|
Cancers
|
|
|
Immune diseases
|
|
|
Neurodegenerative diseases
|
|
|
Substance dependence
|
|
|
Cardiovascular diseases
|
|
|
Endocrine and metabolic diseases
|
|
|
Infectious diseases
|
05110 Vibrio cholerae infection [PATH:hsa05110]
|
05111 Vibrio cholerae pathogenic cycle
|
05120 Epithelial cell signaling in Helicobacter pylori infection [PATH:hsa05120]
|
05130 Pathogenic Escherichia coli infection [PATH:hsa05130]
|
05132 Salmonella infection [PATH:hsa05132]
|
05131 Shigellosis [PATH:hsa05131]
|
05133 Pertussis [PATH:hsa05133]
|
05134 Legionellosis [PATH:hsa05134]
|
05150 Staphylococcus aureus infection [PATH:hsa05150]
|
05152 Tuberculosis [PATH:hsa05152]
|
05100 Bacterial invasion of epithelial cells [PATH:hsa05100]
|
05166 HTLV-I infection [PATH:hsa05166]
|
05162 Measles [PATH:hsa05162]
|
05164 Influenza A [PATH:hsa05164]
|
05161 Hepatitis B [PATH:hsa05161]
|
05160 Hepatitis C [PATH:hsa05160]
|
05168 Herpes simplex infection [PATH:hsa05168]
|
05169 Epstein-Barr virus infection [PATH:hsa05169]
|
05146 Amoebiasis [PATH:hsa05146]
|
05144 Malaria [PATH:hsa05144]
|
05145 Toxoplasmosis [PATH:hsa05145]
|
05140 Leishmaniasis [PATH:hsa05140]
|
05142 Chagas disease (American trypanosomiasis) [PATH:hsa05142]
|
05143 African trypanosomiasis [PATH:hsa05143]
|